Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Stomach Neoplasms × Surgical Procedures, Operative × Clear all

Phase

Status

Sponsor Class

OTHER 34 UNKNOWN 2 NETWORK 2 OTHER_GOV 1 NIH 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 3 Recurrence 2 Fallopian Tube Neoplasms 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Unresectable Non-small Cell Lung Cancer 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Sexual Dysfunction, Physiological 1 Radiation Injuries 1 Prostatic Neoplasms 1 Pilonidal Sinus 1 Pain, Postoperative 1 Pain 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Mouth Neoplasms 1 Melanoma 1 Lung Neoplasms 1 Intestinal Diseases 1 Head and Neck Neoplasms 1 Endometrial Neoplasms 1 Death 1 Colonic Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Adenocarcinoma 1

Interventions

Oxaliplatin 10 Fluorouracil 6 Irinotecan 5 Docetaxel 5 Capecitabine 5 tislelizumab 4 S 1 (combination) 4 Paclitaxel 4 Endoscopic Mucosal Resection 4 XELOX 3 Levoleucovorin 3 Laparoscopy 3 Folfox protocol 3 sintilimab 2 apatinib 2 Proton Pump Inhibitors 2 Gastroenterostomy 2 Gastrectomy 2 vactosertib 1 titanium silicide 1 pembrolizumab 1 lenvatinib 1 durvalumab 1 anlotinib 1 Trastuzumab 1 Tranexamic Acid 1 Tomography, X-Ray Computed 1 Surgical Procedures, Operative 1 Stents 1 Standard of Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04890171 2024-12-27

ERASE-GC

National Cancer Center, Korea

Phase NA Recruiting

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡